Short Interest in HLS Therapeutics Inc. (OTCMKTS:HLTRF) Rises By 3,100.0%

HLS Therapeutics Inc. (OTCMKTS:HLTRF) saw a significant growth in short interest in March. As of March 15th, there was short interest totalling 3,200 shares, a growth of 3,100.0% from the February 28th total of 100 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 32.0 days.

HLS Therapeutics Price Performance

Shares of OTCMKTS:HLTRF traded up $0.05 during trading on Thursday, reaching $3.20. 200 shares of the company’s stock traded hands, compared to its average volume of 923. HLS Therapeutics has a fifty-two week low of $2.22 and a fifty-two week high of $4.00. The company has a 50-day simple moving average of $2.85 and a 200-day simple moving average of $2.66.

HLS Therapeutics Company Profile

HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.